Windtree Therapeutics, Inc. (“Windtree” or the “Company”) (NasdaqCM: WINT), a biotechnology company focused on advancing early and late-stage innovative therapies for critical conditions and diseases, ...
Cardiogenic shock (CS) is a life-threatening condition leading to poor prognosis and high morbidity ... and examining endothelial function and dysfunction in the dynamic microcirculation during ...
Baylor Scott & White The Heart Hospital-Plano in Texas cut times of cardiogenic shock diagnosis in half after implementing a quality improvement project that included nurse education and an ...
Physicians have a new treatment option for many of the sickest pediatric patients with heart failure and cardiogenic shock. Johnson & Johnson MedTech, the global leader in heart recovery, announced ...
Implantation of the Impella CP micro-axial flow pump may increase survival at six months among patients with STEMI complicated by cardiogenic shock (CS), according to the results of the DanGer ...
Progress in assessing cardiovascular risk and identifying early prevention opportunities, improvements in treating heart failure, new therapies for bleeding strokes, strategies for reducing the ...
Hospitals with lower risk-adjusted in-hospital mortality rates (RAMR) among patients with cardiogenic shock following acute myocardial infarction (AMI) demonstrated higher rates of revascularization ...
The patent filing expands upon data obtained from animal model testing and the istaroxime human clinical trials in acute heart failure (AHF) and early cardiogenic shock (ECS), including the latest ...
Editor: On Oct. 8, I was taken to the emergency room by paramedics for cardiogenic shock. Upon arrival my heart rate was at 30 BPM. They were working to stabilize me, but I have a DNR on file. They ...
In addition, consider less-common causes of shock, including cardiogenic shock from myocardial contusion and obstructive shock from cardiac tamponade or tension pneumothorax, which require ...